Диссертация (1141368), страница 30
Текст из файла (страница 30)
2005.108.Энциклопедиялекарствитовароваптечногоассортимента.URL:http://www.rlsnet.ru/tn_index_id_40084.htm (дата обращения 01.03.2015)109. Барскова В.Г. Эффективность и безопасность применения нимесила при подагрическомартрите / В.Г. Барскова [и др.] // Клин. мед. - 2004. - № 82 (12). - С.
49-54.110.A. Lopez-Galindo Compositional, technical and safety specifications of clays to be used aspharmaceutical and cosmetic products / A. Lopez-Galindo, C. Viseras, P. Cerezo.Applied ClayScience. 36. – 2007. – рр. 51–63.111.Ahmed E.M. Hydrogel: Preparation, characterization, and applications / E.M. Ahmed //JAdvRes.2013. URL: http://dx.doi.org/10.1016/j.jare.2013.07.006 (reference date 02.04.2015)112.Alginates / материалы презентации компании FMC BioPolymer.
2011.113.Anlar. S. Physico-Chemical and Bioadhesive Properties of Polyacrylic Acid Polymers / S. Anlar,Y. Capan, A.A. Hincal // Pharmazie. - 48(4). - 1993. – pp.285.114. Allen L. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems Tenth Edition /Loyd V. Allen, Jr, PhD Howard C. Ansel, PhD // Lippincott Williams & Wilkins, a Wolters Kluwerbusiness.ISBN 978-1-4511-8876-9. – 2014.
– pp. 323.115.Anurova M. N. Review of Contemporary Gel-Forming Agents in the Technology of DosageForms / M.N. Anurova, E.O. Bakhrushina, N.B. Demina // Pharmaceutical Chemistry Journal. - Vol.49. Issue 9. - December 2015. - Pp. 627-634116.Aqualon Brochures. Benecel® high purity Methylcellulose, Methylhydroxypropylcellulose,ПО:Hypromellose.AdobeReader.URL:http://www.brenntagspecialties.com/en/downloads/Products/Multi_Market_Principals/Aqualon/Benecel_Brochure.pdf (дата обращения: 20.03.2012).117.BASF(2010)TechnicalInformation.URL:http://www.basf.com195BASF,PharmaIngredients&Services.118.Bentonite.ТехническаяBrenntag.информация.URL:http://www.brenntagspecialties.com/en/pages/Markets_IndustriesServed/Pharmaceuticals/Bentonite/index.html (дата обращения 16.06.2014)119.Breitenbach J. Melt extrusion can bring new benefits to HIV therapy / J. Breitenbach //AmericanJournal of Drug Delivery.
- 2006. - Т. 4. - №. 2. – pp. 61-64.120.British Pharmacopoeia. London. 2009. 10952 c.121.C.Sene et al. Silicones as Excipients for Topical Pharmaceutical Applications. The Silky TouchProducts Family from Dow Corning.2009. p.13.122.Chiarini A. pH‐Solubility Relationship and Partition Coefficients for some Anti‐InflammatoryArylaliphatic Acids / A. Chiarini, A. Tartarini, A. Fini //Archiv der Pharmazie.
- 1984. - Т. 317. - №. 3.- pp. 268-273.123.Clyde M.. Gels and Jellies // Encyclopedia of Pharmaceutical Technology / Clyde M. Ofner III,Cathy M. Klech-Gelotte.// Third Edition. Inc. Pinehurst, North Carolinia, USA. - 2007. - V.3. - P.18851886.124.Daniels R. Technologie Gele für die dermale Applikation / R. Daniels // PharmazeutischeZeitung/ 2002. - № 43.
- S. 29-32.125.Davis А. F. Formulation strategies for modulating skin permeation / Davis А. F [et al.] // In:Walter K. A., editor. Dermatological and transdermal formulations. New York: Dekker; 2002. pp. 271–317.126.DiNunzio J. C. Melt extrusion / DiNunzio J. C. [et al.] //Formulating poorly water soluble drugs.Springer New York. - 2012. - pp. 311-362.127.Dr. Sarfaraz K. Niazi H A N D B O O K O F Pharmaceutical Manufacturing Formulations PartII Formulations of Semisolid Drugs / Dr.
Sarfaraz K. Niazi .2004. by CRC Press LLC.128. European Pharmacopoeia 8.0 ed. 2014. 3162 c.129.Fini A. Fast dispersible/slow releasing ibuprofen tablets / Fini A. [et. al] //European journal ofpharmaceutics and biopharmaceutics. - 2008. - Т. 69. - №. 1. - pp. 335-341.130.FMC Marine Colloids™ Каррагинан. Техническая информация о продукции компанииFMC BioPolymer. 2010.131.Food &Drogs Administration URL: http://www.fda.gov (reference date 12/10/2016)132.Gilles Dumortier Jean Louis Grossiord Florence Agnely Jean Claude Chaumeil A Review ofPoloxamer407PharmaceuticalandPharmacologicalCharacteristics.Junhttp://pharmagateway.net/ArticlePage.aspx?doi=10.1007/s11095-006-9104-413.09.2014)19627,2006(referenceURL:date133.Gryczke A. Development and evaluation of orally disintegrating tablets (ODTs) containingIbuprofen granules prepared by hot melt extrusion / Gryczke A.
[et al.] //Colloids and Surfaces B:Biointerfaces. 2011. – Т. 86. - №. 2. – pp. 275-284.134.Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics ClassificationSystem. – Rockville, MD: U.S. Department of Health and Human Services, FDA, Center for DrugEvaluation and Research.
(CDER), 2000.135.Guru Betageri, Encyclopedia of Pharmaceutical Technology / Guru Betageri, Sunil Prabhu //Third Edition, New York, London. - 2006. - 2092 p.136.Heather A. E. Topical and Transdermal Drug Delivery: Principles and Practice /Heather A. E.,Benson , Adam C., Watkinson. 2012. 464 p.137.Hitesh R. Patel. Poloxamers: A pharmaceutical excipients with therapeutic behaviors / Hitesh R.Patel, Rakesh P. Patel, M.M. Patel.//International Journal of PharmTech Research. Vol.1, No.2, pp 299303 , April-June 2009 ISBN: 978-0-470-25958-0 стр.288138.J.Necas Carrageenan: a review.
/ J.Necas, L.Bartosikova. //Veterinari Medicina. - 58 (4). - 2013.– pp.187-205.139.Japanese Pharmacopei. XV edition. (English version). 2006. 1802 c.140.Javad Shokri Application of Cellulose and Cellulose Derivatives in Pharmaceutical Industries /Javad Shokri and Khosro Adibkia. Vol.3. - iss.2. - 2013.
- pp.58-63.141.Kollicoat MAE 100 P. Техническая информация. The Chemical Company BASF. PharmaIngridients & Services. 2012.142.Kurt I.Draget et al. Alginates from Algae. Weinheim: WILEY-VCH Verlag GmbH&Co. 2005.30p.143.Labarre D.Vauthier, Christine Biomedical and Pharmaceutical Polymers / Labarre, Denis;Ponchel, Gilles France. - 2010. - 176 p144.Laís Bastos da Fonseca Development and Validation of a Discriminative Dissolution Test forNimesulide Suspensions / Laís Bastos da Fonseca, Márcio Labastie, Valéria Pereira de Sousa, NadiaMaria Volpato// AAPS PharmSciTech. 2009 Dec; 10(4): p. 1145.145.Lesko S. M.
An assessment of the safety of pediatric ibuprofen: a practitioner-based randomizedclinical trial / Lesko S. M., Mitchell A. A. //Jama. 1995. Т. 273. №. 12. pp. 929-933.146.Mukai H., Miyagawa S., Iwata M., Kamata H., Eto H. Jpn. Pharmacol.Ther., 29. 2001. Pp. 347–361.147.Ofner C.M., Klech-Gelotte “Gels and jellies” in Encyclopedia of Pharmaceutical Technology, J.Swarbrick, Ed., p.
1875, Informa Health Care, New York, NY, USA, 3rd edition, 2007.148.Osada Y. Gels Handbook, Four-Volume Set – London: Academic Press, 2000.197149.Parasrampuria J., Pitt S.W. “Liquid oral preparations” in Encyclopedia of PharmaceuticalTechnology, J. Swarbrick, Ed., p. 2216, Informa Health Care, New York, NY, USA, 3rd edition, 2007.150.Perrott D. A. et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children's painor fever: a meta-analysis //Archives of pediatrics & adolescent medicine. 2004. Т. 158.
№. 6. pp. 521526.151.Pharmaceutical Manufacturing Handbook Production and Processes SHAYNE COX GAD,PH.D., D.A.B.T. Gad Consulting Services Cary, North Carolina A JOHN WILEY & SONS, INC.,PUBLICATION. 2008.152.Pharmacopeia of the United State. USP 38/ NF 33. 2015.153.Pierce C. A., Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults:a meta-analysis and qualitative review //Annals of Pharmacotherapy. 2010.
Т. 44. №. 3. pp. 489-506.154.Podczeck F. “Reology of pharmaceutical systems” in Encyclopedia of PharmaceuticalTechnology, J. Swarbrick, Ed., p. 3128, Informa Health Care, New York, NY, USA, 3rd edition, 2007.155.Rabisková M., Sedláková M., Vitková M., Kuna M. Carbomers and their use in pharmaceuticaltechnology. Ceska Slov Farm. 2004 Nov. 53(6). Pp.300-303.156.Rainsford K. D. Ibuprofen: pharmacology, efficacy and safety //Inflammopharmacology.
2009.Т. 17. №. 6. pp. 275-342.157.Rainsford K.D. Nimesulide. Actions and Uses. Birkhaeuser Verlag, Basel-Boston-Berlin. 2005.417 p.158. Ravichandran Mahalingam, Xiaoling Li, Bhaskara R. Jasti. Semisolid Dosages: Ointments,Creams, and Gels. Pharmaceutical manufacturing. Production and Processes.
Canada: 2008. 267-313 p.159.Reddy B. B. K., Karunakar A. Biopharmaceutics classification system: a regulatory approach//Dissolution Technol. 2011. Т. 18. №. 1. pp. 31-37.160.Rojas, J. & Kumar, V. (2011). Comparative evaluation of silicified microcrystalline cellulose IIas a direct compression vehicle. International Journal of Pharmaceutics, Volume 416, Issue 1 (15September), Pages 120-128.161.S. O. Obaje, J. I. Omada and U. A.
Dambatta. Clays and their Industrial Applications: SynopticReview. IJST. Vol.4 №5. 2013. Pp.264-270.162.Sassa R., Saito S., Ihori M., Unuma T., J. New Rem. &Clin., 44. 1995. pp.1139–1161.163.Scherer G.W., Brinker C.J. Sol-Gel Science. San Diego.: Academic Press, 1990. 908 p.164.Scheytt T.
et al. 1-Octanol/water partition coefficients of 5 pharmaceuticals from human medicalcare: carbamazepine, clofibric acid, diclofenac, ibuprofen, and propyphenazone //Water, Air, and SoilPollution. 2005. Т. 165. №. 1-4. pp. 3-11.165.Stefana-Oana Purcaru, Mihaela Ionescu, Cristina Raneti, Valentina Anuta, I. Mircioiu,Ionela Belu. Study of Nimesulide Release from Solid Pharmaceutical Formulations in Tween 80198Solutions//Currenthealthsciencesjornal.Vol36,No.1,2010.URL:http://www.chsjournal.org/archive/vol-36-no1-2010/original-papers/study-of-nimesulide-release-fromsolid-pharmaceutical-formulations-in-tween-80-solutions (reference date 09.08.2016)166.Susana Simões, Ana Figueiras, Francisco Veiga, Modular Hydrogels for Drug Delivery // Journalof Biomaterials and Nanobiotechnology.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
